Wound Healing Technologies in Clinical Application

Wound healing technologies encompass a spectrum of strategies designed to restore skin integrity in acute and chronic injuries. Innovations range from advanced dressings and biomimetic scaffolds to growth-factor delivery systems and cell-based therapies. Central to these approaches is the recreation of a provisional extracellular matrix that supports cell migration, proliferation and neovascularisation. Synthetic electrospun matrices offer controlled porosity and tunable degradation, while biologically derived or hybrid materials can provide native adhesion sites and mechanical strength. Adjunctive modalities, including cytokine or antibody-targeted treatments, further modulate the inflammatory phase to prevent chronicity. In clinical practice, these technologies have been applied to diabetic foot ulcers, venous leg ulcers, pressure sores, radiation-induced wounds and surgical defects. The global burden of non-healing wounds drives ongoing translation of preclinical findings into human trials, with a focus on cost-effective, off-the-shelf products that combine ease of application with robust regenerative potential.

Research from Nature Portfolio

Recent studies have elucidated the importance of extracellular matrix components in compromised healing contexts. In a preclinical model of radiation-damaged skin, proteomic profiling revealed a marked decline in fibronectin expression. Topical restoration of fibronectin accelerated wound closure, attenuated local inflammation and enhanced new blood-vessel formation, thereby demonstrating that targeted replacement of key matrix proteins can reinstate normal repair mechanisms. This work highlights the potential of precision biomolecular therapies to rescue healing in tissues rendered refractory by prior treatments.

Wound Healing Technologies in Clinical Application publication trend

The graph below shows the total number of articles in wound healing technologies in clinical application across all publications each year (not limited to Nature Index journals).

Technical terms

Extracellular matrix (ECM): A three-dimensional network of proteins and polysaccharides that provides structural support and biochemical cues for cell attachment and migration.

Electrospun matrix: A fibrous scaffold produced by electrically drawing polymer solutions into nano- to microscale fibres, offering high surface area and controlled porosity.

Re-epithelialisation: The process by which keratinocytes migrate over a wound bed to restore the epidermal barrier.

Neovascularisation (angiogenesis): The growth of new blood vessels from existing vasculature, essential for supplying nutrients and oxygen to healing tissue.

References

1. What Makes the Optimal Wound Healing Material? A Review of Current Science and Introduction of a Synthetic Nanofabricated Wound Care Scaffold. Cureus (2017).
2. Topical Fibronectin Improves Wound Healing of Irradiated Skin. Scientific Reports (2017).
3. Clinical Application of Bioresorbable, Synthetic, Electrospun Matrix in Wound Healing. Bioengineering (2022).
4. Evaluation of wound healing of diabetic foot ulcers in a prospective clinical trial using a synthetic hybrid-scale fiber matrix. Foot & Ankle Surgery Techniques Reports & Cases (2022).
5. α-Gal Nanoparticles Mediated Homing of Endogenous Stem Cells for Repair and Regeneration of External and Internal Injuries by Localized Complement Activation and Macrophage Recruitment. International Journal of Molecular Sciences (2022).